Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules.
about
Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routesInduction of intestinal immunity by mucosal vaccines as a means of controlling HIV infectionSynthetic DNA vaccine strategies against persistent viral infectionsImmunology of Gut Mucosal VaccinesMucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design.Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccinesPrime-boost vaccination using chemokine-fused gp120 DNA and HIV envelope peptides activates both immediate and long-term memory cellular responses in rhesus macaquesLong-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization.Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in miceA replicating adenovirus capsid display recombinant elicits antibodies against Plasmodium falciparum sporozoites in Aotus nancymaae monkeys.Biogeography of the intestinal mucosal and lumenal microbiome in the rhesus macaque.T-cell-biased immune responses generated by a mucosally targeted adenovirus-σ1 vaccineInduction of mucosal HIV-specific B and T cell responses after oral immunization with live coxsackievirus B4 recombinantsA single sublingual dose of an adenovirus-based vaccine protects against lethal Ebola challenge in mice and guinea pigs.Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV.Enhanced induction of intestinal cellular immunity by oral priming with enteric adenovirus 41 vectors.Delivery of human immunodeficiency virus vaccine vectors to the intestine induces enhanced mucosal cellular immunityA single intraduodenal administration of human adenovirus 40 vaccine effectively prevents anaphylactic shock.Delivery systems: a vaccine strategy for overcoming mucosal tolerance?Strategies for optimizing targeting and delivery of mucosal HIV vaccines.Molecular basis of the mucosal immune system: from fundamental concepts to advances in liposome-based vaccines.Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials.Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus VaccinesPhenotypic and Functional Characterization of Peripheral Blood Lymphocytes from Various Age- and Sex-Specific Groups of Owl Monkeys (Aotus nancymaae).Lessons on Non-Progression of HIV Disease from Monkeys.A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses.HIV infection and specific mucosal immunity: workshop 4B.Firewalls Prevent Systemic Dissemination of Vectors Derived from Human Adenovirus Type 5 and Suppress Production of Transgene-Encoded Antigen in a Murine Model of Oral Vaccination.Coated hard capsules as the pH-dependent drug transport systems to ileo-colonic compartment
P2860
Q22241377-A23363AC-9BCC-4EC6-ADDC-7B5967AD21DAQ27001897-FF48F099-83F8-4B80-9499-18D093DA51F8Q27016078-FE8B0D0B-E67E-4F9E-9981-1A6A21F30973Q28972559-B7980885-3D1F-4323-8E0F-E0073B6A9D8FQ30375160-C06AFE7A-2ADE-4AB0-87DD-22877B59C7BBQ33424498-2395DD95-3E32-4019-88FD-EA0A06D910F8Q33829574-66010C90-50DD-4894-979F-49DC8981B6E8Q34099837-0B1A9B62-6C62-45BA-9C57-4F0BD1DF9916Q34510430-BC952B27-626C-4652-A87F-68C3306A8B02Q34889790-2CBB7709-5F94-49F2-8C5A-6FC9AA0119B2Q35206392-7B13B4A6-627C-48E8-96BD-9EC1FF173BE3Q35894806-CC83EEEC-9599-4ACC-AEEE-833DDB0BF993Q35973518-50A8F8B5-64EE-4679-B6FB-80DF4AB31352Q35980530-D03423AD-0499-4C00-9028-3C2A0CE02579Q36981370-55B63876-F6E9-4AFB-9009-4C958356EDACQ37033283-D7203333-637B-4F93-BEBD-8529C263D3F4Q37247948-1C7038D4-99DE-4259-A564-352716CA1F2AQ37252311-B1503B95-8C0F-4AFA-94E0-668A9286C80AQ37354182-D80B0ED8-CC51-44AC-81B4-F33D1789B8EDQ37554135-16A968CA-1F1E-478F-9EE0-8F8A7C4D0D48Q37818335-850B4C6B-24CE-4917-927E-99DEB6505A01Q38096490-0042BBD2-6BD0-4BD5-93EC-5286A22EEBFCQ39582556-B9E0D2AD-7785-4D0F-816C-79424F3EB8F4Q40323412-3372AB7D-350B-4650-A617-656C4FB8E6A0Q41214512-B5B2C527-F686-4FA8-9241-741D338AAF5DQ43990531-36F4A802-6DB2-4B54-BFB5-AC9F8F03E796Q43994786-D13A08CC-C4B2-42F1-88EC-C0058405E4CFQ49167770-C96DBB08-4D71-44C2-97C9-AE9AC2088F46Q57119804-3A5D0760-86E4-43C7-989E-0D0423ABDAD7
P2860
Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Oral immunization of rhesus ma ...... using enteric-coated capsules.
@ast
Oral immunization of rhesus ma ...... using enteric-coated capsules.
@en
type
label
Oral immunization of rhesus ma ...... using enteric-coated capsules.
@ast
Oral immunization of rhesus ma ...... using enteric-coated capsules.
@en
prefLabel
Oral immunization of rhesus ma ...... using enteric-coated capsules.
@ast
Oral immunization of rhesus ma ...... using enteric-coated capsules.
@en
P2093
P2860
P921
P1433
P1476
Oral immunization of rhesus ma ...... using enteric-coated capsules
@en
P2093
Bharti N Nehete
Eric A Weaver
George T Mercier
Kimberly Schluns
Marco F Passeri
Michael A Barry
Nancy Smyth Templeton
Pramod N Nehete
Stephanie S Buchl
P2860
P304
P356
10.1016/J.VACCINE.2007.10.030
P407
P50
P577
2007-11-05T00:00:00Z